Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Scrip Asia 100 logo

2024 Scrip Asia 100

Latest Updates And Considerations In Asia Pacific


Indian manufacturers leverage smart technologies and data-driven processes to deliver meaningful gains, while US-China collaboration becomes vital to survive ongoing drug shortages.

Indian ‘Lighthouses’ Deliver Gains Amid Price Erosion, Rising Input Costs

Senior executives from Dr Reddy’s and Cipla showcase the “step-change” in performance across cost, quality and delivery metrics at their ‘lighthouse’ manufacturing sites in India as industry tackles dwindling operating margins and evolving compliance requirements. 

Commercial Manufacturing India

China Steps In To Help Relieve US Cancer Drug Shortages

At least one major Chinese supplier is being tapped to relieve a shortage of certain drugs in the US despite rising Beijing-Washington tensions, but China may be increasingly unwilling to co-operate amid its own shifting economic priorities, increasingly introspective policies and some shortages of its own. 

China Cancer Manufacturing